Genetic Signatures Ltd. (AU:GSS)
ASX:GSS
Total Valuation
Genetic Signatures Ltd. has a market cap or net worth of AU$18.17M. The enterprise value is AU$1.63M.
Market CapAU$18.17M
Enterprise ValueAU$1.63M
Share Statistics
Genetic Signatures Ltd. has 227,138,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,138,820
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genetic Signatures Ltd.’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -29.06%.
Return on Equity (ROE)-0.40
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-29.06%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee135.90K
Profits Per Employee0.00
Employee Count117
Asset Turnover0.29
Inventory Turnover0.90
Valuation Ratios
The current PE Ratio of Genetic Signatures Ltd. is ―. Genetic Signatures Ltd.’s PEG ratio is 0.21.
PE Ratio―
PS Ratio5.20
PB Ratio1.65
Price to Fair Value1.65
Price to FCF-6.27
Price to Operating Cash Flow-1.89
PEG Ratio0.21
Income Statement
In the last 12 months, Genetic Signatures Ltd. had revenue of 15.90M and earned -20.10M in profits. Earnings per share was -0.09.
Revenue15.90M
Gross Profit7.78M
Operating Income-18.48M
Pretax Income-20.10M
Net Income-20.10M
EBITDA-16.08M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -9.60M and capital expenditures -1.07M, giving a free cash flow of -10.67M billion.
Operating Cash Flow-9.60M
Free Cash Flow-10.67M
Free Cash Flow per Share-0.05
Dividends & Yields
Genetic Signatures Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change-80.25%
50-Day Moving Average0.11
200-Day Moving Average0.25
Relative Strength Index (RSI)36.41
Average Volume (3m)149.45K
Important Dates
Genetic Signatures Ltd. upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Genetic Signatures Ltd. as a current ratio of 11.70, with Debt / Equity ratio of 1.48%
Current Ratio11.70
Quick Ratio9.49
Debt to Market Cap<0.01
Net Debt to EBITDA0.42
Interest Coverage Ratio-203.09
Taxes
In the past 12 months, Genetic Signatures Ltd. has paid -3.85M in taxes.
Income Tax-3.85M
Effective Tax Rate0.19
Enterprise Valuation
Genetic Signatures Ltd. EV to EBITDA ratio is -4.73, with an EV/FCF ratio of -5.77.
EV to Sales4.78
EV to EBITDA-4.73
EV to Free Cash Flow-5.77
EV to Operating Cash Flow-6.19
Balance Sheet
Genetic Signatures Ltd. has AU$29.87M in cash and marketable securities with AU$653.00K in debt, giving a net cash position of AU$29.22M billion.
Cash & Marketable SecuritiesAU$29.87M
Total DebtAU$653.00K
Net CashAU$29.22M
Net Cash Per ShareAU$0.13
Tangible Book Value Per ShareAU$0.22
Margins
Gross margin is -80.05%, with operating margin of -116.23%, and net profit margin of -126.44%.
Gross Margin-80.05%
Operating Margin-116.23%
Pretax Margin-126.44%
Net Profit Margin-126.44%
EBITDA Margin-101.11%
EBIT Margin-116.23%
Analyst Forecast
The average price target for Genetic Signatures Ltd. is AU$0.10, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$0.10
Price Target Upside-58.33% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast62.81%
EPS Growth Forecast16.37%